| Date Filed | Type | Description |
| 03/02/2023 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 718 shares
@ $28, valued at
$20.1k
Granted 18,500 shares
@ $0 |
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 734 shares
@ $29.26, valued at
$21.5k
|
|
| 12/21/2022 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 461 shares
@ $30.03, valued at
$13.8k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 805 shares
@ $45.03, valued at
$36.2k
|
|
| 02/01/2022 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 626 shares
@ $45.94, valued at
$28.8k
|
|
| 01/11/2022 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 263 shares
@ $50.63, valued at
$13.3k
|
|
| 01/07/2022 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 738 shares
@ $50.69, valued at
$37.4k
|
|
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 8,900 shares
@ $0 |
|
| 02/02/2021 |
4
| Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 637 shares
@ $46.67, valued at
$29.7k
|
|
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2020 |
3
| Cahill Brian Joseph (CFO) has filed a Form 3 on EAGLE PHARMACEUTICALS, INC. |